Associations Between Common Polymorphisms of CDKN2B-AS and Susceptibility to ASCVD.

Angiology
Yupeng HuangGuokang Yang

Abstract

This meta-analysis was conducted to estimate associations between CDKN2B antisense (CDKN2B-AS) polymorphisms and susceptibility to atherosclerotic cardio-cerebral vascular diseases (ASCVD). A systematic literature research of PubMed, Medline, Web of Science, Embase, and CNKI was performed to identify eligible studies. Overall, 34 studies were included for meta-analyses. Pooled overall analyses showed that rs1333040, rs1333049, rs2383206, and rs2383207 polymorphisms were associated with susceptibility to ASCVD in the whole population. Further analyses by ethnicity revealed that all investigated polymorphisms were associated with susceptibility to ASCVD in East Asians. Moreover, rs2383206, rs2383207, rs10757274, and rs10757278 polymorphisms were associated with susceptibility to ASCVD in West Asians, while rs2383206, rs10757274, and rs10757278 were associated with susceptibility to ASCVD in Caucasians. When we stratified eligible studies by type of disease, positive results were found for all investigated polymorphisms in patients with coronary artery disease (CAD) or myocardial infarction, whereas positive results were only detected for rs2383206 and rs10757274 polymorphisms in patients with ischemic stroke (IS). Our findings su...Continue Reading

References

May 13, 2004·JAMA : the Journal of the American Medical Association·Donald M Lloyd-JonesChristopher J O'Donnell
Sep 29, 2004·Circulation·Aldons J LusisGregg C Fonarow
Oct 6, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Björn MayerHeribert Schunkert
Apr 20, 2007·American Journal of Epidemiology·Alanna C MorrisonEric Boerwinkle
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Apr 14, 2011·Current Atherosclerosis Reports·Michael S Cunnington, Bernard Keavney
May 20, 2011·Nature·Peter LibbyGöran K Hansson
Nov 19, 2011·Nature Reviews. Genetics·Manel Esteller
Jan 12, 2012·Circulation. Cardiovascular Genetics·George ThanassoulisChristopher J O'Donnell
Apr 18, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Veronica J Peschansky, Claes Wahlestedt
Dec 30, 2014·Cardiovascular & Hematological Agents in Medicinal Chemistry·Andrea RognoniAngelo S Bongo
Feb 4, 2016·World Journal of Cardiology·Xuming DaiMarschall S Runge
May 18, 2016·EMBO Molecular Medicine·Thorsten KesslerHeribert Schunkert
Sep 4, 2018·Experimental and Molecular Pathology·Hao SunHongmei Qiao

❮ Previous
Next ❯

Software Mentioned

Review Manager

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.